Dihydroergotamine Mesylate Injection, solution for injection, USP, 1 mg/mL Ampules, Rx Only, Distributed by: Provepharm Inc. 100 Springhouse Drive Suite 105, Collegeville, PA 19426, NDC 81284-411-05

FDA recall notice · announced December 25, 2024 · Provepharm

Class II FDA/FSIS Class II: use may cause temporary or medically reversible adverse health consequences.

The product

Dihydroergotamine Mesylate Injection, solution for injection, USP, 1 mg/mL Ampules, Rx Only, Distributed by: Provepharm Inc. 100 Springhouse Drive Suite 105, Collegeville, PA 19426, NDC 81284-411-05

Reason for recall

Discoloration

Notes

Distribution: Nationwide within the United States
Lot/code information: Lot #: F9026F01, F9026F02, Exp. Date 12/2025
Quantity: 2160 packs/5 ampules per pack = 10,800 ampules
Status: Ongoing
Products in this recall event:
- Dihydroergotamine Mesylate Injection, solution for injection, USP, 1 mg/mL Ampules, Rx Only, Distributed by: Provepharm Inc. 100 Springhouse Drive Suite 105, Collegeville, PA 19426, NDC 81284-411-05 (D-0150-2025)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.